---
annotations:
- type: Pathway Ontology
  value: sphingolipid metabolic pathway
authors:
- ReactomeTeam
- Anwesha
- Fehrhart
description: 'Sphingolipids are derivatives of long chain sphingoid bases such as
  sphingosine (trans-1,3-dihydroxy 2-amino-4-octadecene), an 18-carbon unsaturated
  amino alcohol which is the most abundant sphingoid base in mammals. Amide linkage
  of a fatty acid to sphingosine yields ceramides. Esterification of phosphocholine
  to ceramides yields sphingomyelin, and ceramide glycosylation yields glycosylceramides.
  Introduction of sialic acid residues yields gangliosides. These molecules appear
  to be essential components of cell membranes, and intermediates in the pathways
  of sphingolipid synthesis and breakdown modulate processes including apoptosis and
  T cell trafficking.<p>While sphingolipids are abundant in a wide variety of foodstuffs,
  these dietary molecules are mostly degraded by the intestinal flora and intestinal
  enzymes. The body primarily depends on de novo synthesis for its sphingolipid supply
  (Hannun and Obeid 2008; Merrill 2002). De novo synthesis proceeds in four steps:
  the condensation of palmitoyl-CoA and serine to form 3-ketosphinganine, the reduction
  of 3-ketosphinganine to sphinganine, the acylation of sphinganine with a long-chain
  fatty acyl CoA to form dihydroceramide, and the desaturation of dihydroceramide
  to form ceramide.<p>Other sphingolipids involved in signaling are derived from ceramide
  and its biosynthetic intermediates. These include sphinganine (dihydrosphingosine)
  1-phosphate, phytoceramide, sphingosine, and sphingosine 1-phosphate.<p>Sphingomyelin
  is synthesized in a single step in the membrane of the Golgi apparatus from ceramides
  generated in the endoplasmic reticulum (ER) membrane and transferred to the Golgi
  by CERT (ceramide transfer protein), an isoform of COL4A3BP that is associated with
  the ER membrane as a complex with PPM1L (protein phosphatase 1-like) and VAPA or
  VAPB (VAMP-associated proteins A or B). Sphingomyelin synthesis appears to be regulated
  primarily at the level of this transport process through the reversible phosphorylation
  of CERT (Saito et al. 2008).<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=428157
  Reactome].'
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP2788
- /instance/WP2788
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP2788.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: 'Sphingolipids are derivatives of long chain sphingoid bases such as
    sphingosine (trans-1,3-dihydroxy 2-amino-4-octadecene), an 18-carbon unsaturated
    amino alcohol which is the most abundant sphingoid base in mammals. Amide linkage
    of a fatty acid to sphingosine yields ceramides. Esterification of phosphocholine
    to ceramides yields sphingomyelin, and ceramide glycosylation yields glycosylceramides.
    Introduction of sialic acid residues yields gangliosides. These molecules appear
    to be essential components of cell membranes, and intermediates in the pathways
    of sphingolipid synthesis and breakdown modulate processes including apoptosis
    and T cell trafficking.<p>While sphingolipids are abundant in a wide variety of
    foodstuffs, these dietary molecules are mostly degraded by the intestinal flora
    and intestinal enzymes. The body primarily depends on de novo synthesis for its
    sphingolipid supply (Hannun and Obeid 2008; Merrill 2002). De novo synthesis proceeds
    in four steps: the condensation of palmitoyl-CoA and serine to form 3-ketosphinganine,
    the reduction of 3-ketosphinganine to sphinganine, the acylation of sphinganine
    with a long-chain fatty acyl CoA to form dihydroceramide, and the desaturation
    of dihydroceramide to form ceramide.<p>Other sphingolipids involved in signaling
    are derived from ceramide and its biosynthetic intermediates. These include sphinganine
    (dihydrosphingosine) 1-phosphate, phytoceramide, sphingosine, and sphingosine
    1-phosphate.<p>Sphingomyelin is synthesized in a single step in the membrane of
    the Golgi apparatus from ceramides generated in the endoplasmic reticulum (ER)
    membrane and transferred to the Golgi by CERT (ceramide transfer protein), an
    isoform of COL4A3BP that is associated with the ER membrane as a complex with
    PPM1L (protein phosphatase 1-like) and VAPA or VAPB (VAMP-associated proteins
    A or B). Sphingomyelin synthesis appears to be regulated primarily at the level
    of this transport process through the reversible phosphorylation of CERT (Saito
    et al. 2008).<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=428157
    Reactome].'
  keywords:
  - SUMF1
  - GalNAc
  - 'ARSK '
  - 'CERS4 '
  - PXLP-SGPL1
  - ARS
  - O2
  - PPAP2
  - 'ARSA(448-507) '
  - GBA2
  - active STS dimer
  - UDP-Gal
  - C1P
  - UDP-GalNAc
  - 'ARSH '
  - 'GD3 '
  - GD3,GM3
  - 'PXLP-K371-SPTLC3 '
  - SPG
  - N-acylphytosphingosine
  - 'VAPA '
  - 'ARSA(19-444) '
  - 'SGPP1 '
  - ACER1
  - CSNK1G2
  - 'OxA-ARSD '
  - ceramide:CERT:PPM1L:VAPA/B trimer
  - ORMDL1,2,3
  - SPHM
  - CO2
  - GM3
  - OSBP
  - active ARS
  - GLTPD1
  - STEA
  - 'OxA-ARSH '
  - NEU1,4
  - 'ARSE '
  - NAD+
  - SUMF1:SUMF2
  - HEXA
  - phytosphingosine
  - 'ESYT2 '
  - Neu5Ac
  - SGPP
  - DEGS1
  - 'NADP+ '
  - 2xPalmC-SGMS2
  - PE
  - HD2NAL
  - ALDH3A2-1 dimer
  - trimer
  - GM2
  - 'SPHK1 '
  - SPNS2
  - 'Mg2+ '
  - GalCer
  - GLA dimer
  - SMPD1
  - ACER3
  - SPHK2
  - 'SUMF1 '
  - PRKD1,2,3
  - Glucosylceramide
  - GPL
  - 'GBA '
  - PETA
  - 'CTSA(327-480) '
  - 'CERS1 '
  - PALM-CoA
  - 'SPTSSB '
  - 'OxA-ARSI '
  - Pi
  - (Rhodopsin-like
  - 'B4GALNT1 '
  - active ARSA:Ca2+
  - 'OxA-ARSE '
  - 'PPM1L '
  - 'OxA-STS '
  - SPHK1
  - NADH
  - Class A/1
  - 'OxA-ARSA(19-444) '
  - PPAP2A
  - 'PPAP2C '
  - 'SPTSSA '
  - DHEA-SO4
  - GM1
  - GBA:SAPC
  - 'GM2 '
  - Sulfatide
  - receptors)
  - Gal
  - Glc
  - 'GLA '
  - SO4(2-)
  - ENPP7
  - 2HCERA
  - 'ARSD '
  - 'CERS3 '
  - 'CTSA(29-326) '
  - GM2A:GM2
  - 'SMPD3 '
  - 'p-S,S132,T-COL4A3BP-2 '
  - B4GALNT1 dimer
  - SMPD4:Mg2+
  - SAMD8
  - 'ESYT3 '
  - 'PXLP-K379-SPTLC2 '
  - FA2H
  - 'NEU1 '
  - SGMS1
  - 'NEU4-2 '
  - SPHK
  - H2S
  - ALDH3B1
  - 'GLB1 '
  - 'Ca2+ '
  - SMPD2,3:Mg2+
  - H+
  - 'ESYT1 '
  - DAGs
  - L-Ser
  - 'GM2A(32-193) '
  - 'ASAH2 '
  - 'CERS2 '
  - Gb4Cer
  - ST-CoA
  - 'NAD+ '
  - ASAH2-like proteins
  - 'SPHK2 '
  - N-acylsphingosine
  - 'OxA-ARSG '
  - Globoside
  - 'SMPD2 '
  - 'PPAP2B '
  - 'PRKD3 '
  - GLTP
  - 'STS '
  - 'SMPD4 '
  - multiphospho-CERT:PPM1L:VAPA/B trimer
  - ADP
  - CERA
  - 'PRKD2 '
  - 'opaganib '
  - Ca2+
  - LacCer
  - NAD(P)+
  - CoA-SH
  - DEGS2
  - SUMF2
  - 'OxA-ARSB '
  - 'VAPB '
  - 'OxA-ARSK '
  - 'ARSI '
  - H2O
  - 'NADH '
  - 'CERS6 '
  - ChoP
  - UGCG
  - 'ARSF '
  - 'ORMDL3 '
  - p-S,S132,T-COL4A3BP-2
  - 'ARSG '
  - GSL
  - 3-ketosphinganine
  - 'CERS5 '
  - 'ORMDL2 '
  - GM2A(32-193)
  - LASS proteins
  - 'ASAH1(22-142) '
  - ATP
  - DHEA
  - ASAH1
  - ESYT1:ESYT2:ESYT3
  - 'ARSB '
  - 'GD2 '
  - RCOOH
  - NADPH
  - 'PPAP2A '
  - 'COL4A3BP-2 '
  - NADP+
  - CPE
  - CERT:PPM1L:VAPA/B
  - HXAL
  - GALC
  - ACER2
  - COL4A3BP-2
  - 'HEXA '
  - 'GM3 '
  - 'PRKD1 '
  - PPM1L:VAPA/B dimer
  - p-S132-COL4A3BP-2
  - 'HEXB(315-556) '
  - PALM
  - ALDH3B2
  - PC
  - 'OxA-ARSF '
  - SPTLC complexes
  - 'GLB1L '
  - 'SUMF2 '
  - 'ALDH3A2-1 '
  - 'PXLP-K-SPTLC1 '
  - SPA
  - 'ASAH1(143-395) '
  - KDSR
  - BGAL
  - 'HEXB(122-311) '
  - 'ARSJ '
  - B3GALNT1
  - UGT8
  - SPAP
  - CERK
  - UDP-Glc
  - NAD(P)H
  - SPHK2:SPHK2
  - GBA3
  - UDP
  - HEXA,B
  - NEU2
  - 'SGPP2 '
  - 'CERA '
  - S1P
  - GD2,GM2
  - inhibitors
  - NEU3
  - 'OxA-ARSJ '
  - 'NADPH '
  - 'PSAP(311-391) '
  - Gb3Cer
  - 'ORMDL1 '
  - DHCE
  license: CC0
  name: Sphingolipid metabolism
seo: CreativeWork
title: Sphingolipid metabolism
wpid: WP2788
---